Observations placeholder
Alkeran and Melphalan
Identifier
017979
Type of Spiritual Experience
Number of hallucinations: 6
Background
A description of the experience
Melphalan (trade name Alkeran, in former USSR also known as Sarcolysin) is a chemotherapy drug . It is used to treat multiple myeloma, ovarian cancer, AL amyloidosis, and occasionally malignant melanoma. The agent was first investigated as a possible drug for use in melanoma. It was not found to be effective, but has been found to be effective in the treatment of myeloma.
Melphalan is currently being used to treat ocular retinoblastoma, a pediatric solid tumor. This is accomplished via transarterial catheter based slow pulsed infusion into the ophthalmic artery.
On Oct, 8, 2015: 3,236 people reported to have side effects when taking Alkeran. Among them, 6 people (0.15%) have Hallucination.
Time on Alkeran when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Alkeran:
| Female | Male | |
| Hallucination | 25.00% | 75.00% |
Age of people who have Hallucination when taking Alkeran :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |